Chinese vaccine manufacturer is fined $1.3 billion

| By | China, Drug Quality Control, Vaccine Production

Changchun Changsheng Life Sciences, a Chinese pharmaceutical company and manufacturer of rabies vaccine, was fined 9.1 billion yuan ($1.3 billion) for falsifying production records in a scandal that prompted a nationwide crackdown on the industry.

Disclosure of the case, and the failure of authorities to act immediately after finding inconsistencies in the company’s records in late 2017, triggered a public outcry following deaths and injuries due to fake or shoddy medicines, milk, toys and other products.

Changchun Changsheng Life Sciences, which was ordered in July to suspend production, also was stripped of its licenses to make vaccines and drugs, the State Drug Administration announced.

Rabies is endemic in parts of China. No injuries were reported from use of Changsheng Life Science’s vaccines, but authorities ordered a recall of its products from Chinese and foreign markets. The company’s chief executive and 14 other managers were detained in July after a surprise inspection found falsified production and inspection records starting as early as 2014.

Changsheng Life Sciences used expired materials, mixed different batches of products and failed to test them properly. According to recent announcement, the company destroyed records to conceal its misconduct.

SOURCE: apnews
GMP news
Pharmaceutical industry News and events. Technology transfer and contract manufacturing of medicines.